-
1
-
-
32944465862
-
Managing a fateful alliance: anaemia and cardiovascular outcomes
-
Eckardt K.U. Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 2005, 20(suppl 6):vi16-vi20.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. vi16-vi20
-
-
Eckardt, K.U.1
-
2
-
-
0034765367
-
Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%
-
Collins A.J., Li S., St Peter W., et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 2001, 12:2465-2473.
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 2465-2473
-
-
Collins, A.J.1
Li, S.2
St Peter, W.3
-
3
-
-
33645474065
-
Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
-
Regidor D.L., Kopple J.D., Kovesdy C.P., et al. Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006, 17:1181-1191.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 1181-1191
-
-
Regidor, D.L.1
Kopple, J.D.2
Kovesdy, C.P.3
-
4
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998, 339(suppl 9):584-590.5.
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590.5
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
-
5
-
-
33750983605
-
CHOIR investigators: correction of anemia with epoetin alfa in chronic kidney disease
-
Singh A.K., Szczech L., Tang K.L., et al. CHOIR investigators: correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006, 355:2085-2098.
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
-
6
-
-
33751002326
-
Normalization of Hb level in patients with chronic kidney disease and anemia
-
Drüeke T.B., Locatelli F., Clyne N., et al. Normalization of Hb level in patients with chronic kidney disease and anemia. N Engl J Med 2006, 355(suppl 20):2071-2084. CREATE Investigators.
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drüeke, T.B.1
Locatelli, F.2
Clyne, N.3
-
7
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
-
Phrommintikul A., Haas S.J., Elsik M., Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007, 369:381-388.
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Krum, H.4
-
8
-
-
70949108082
-
A trial of darbopoetin alfa in type 2 diabetes and chronic kidney disease
-
Pfeffer M.A., Burdmann E.A., Chen C.Y., et al. A trial of darbopoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009, 361:2019-2032. TREAT Investigators.
-
(2009)
N Engl J Med
, vol.361
, pp. 2019-2032
-
-
Pfeffer, M.A.1
Burdmann, E.A.2
Chen, C.Y.3
-
9
-
-
77957311438
-
Conversion of darbepoetin to low doses of CERA maintains Hb levels in non-dialysis chronic kidney disease patients
-
Minutolo R., Zamboli P., Chiodini P., et al. Conversion of darbepoetin to low doses of CERA maintains Hb levels in non-dialysis chronic kidney disease patients. Blood Purif 2010, 30:186-194.
-
(2010)
Blood Purif
, vol.30
, pp. 186-194
-
-
Minutolo, R.1
Zamboli, P.2
Chiodini, P.3
-
10
-
-
80053913535
-
Prognosis of CKD patients receiving outpatient nephrology care in Italy
-
De Nicola L., Chiodini P., Zoccali C., et al. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol 2011, 6:2421-2428. SIN-TABLE CKD Study Group.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 2421-2428
-
-
De Nicola, L.1
Chiodini, P.2
Zoccali, C.3
-
11
-
-
77955722809
-
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease
-
Palmer S.C., Navaneethan S.D., Craig J.C., et al. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 2010, 153:23-33.
-
(2010)
Ann Intern Med
, vol.153
, pp. 23-33
-
-
Palmer, S.C.1
Navaneethan, S.D.2
Craig, J.C.3
-
12
-
-
77956704796
-
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
-
Solomon S.D., Uno H., Lewis E.F., et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 2010, 363:1146-1155. Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators.
-
(2010)
N Engl J Med
, vol.363
, pp. 1146-1155
-
-
Solomon, S.D.1
Uno, H.2
Lewis, E.F.3
-
13
-
-
84155164794
-
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darboetin alfa: the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) experience
-
Skali H., Parving H.H., Parfrey P.S., et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darboetin alfa: the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) experience. Circulation 2011, 124:2903-2908.
-
(2011)
Circulation
, vol.124
, pp. 2903-2908
-
-
Skali, H.1
Parving, H.H.2
Parfrey, P.S.3
-
14
-
-
16844375873
-
Distribution of C-reactive protein values in the United States
-
Woloshin S., Schwartz L.M. Distribution of C-reactive protein values in the United States. N Engl J Med 2005, 352:1611-1613.
-
(2005)
N Engl J Med
, vol.352
, pp. 1611-1613
-
-
Woloshin, S.1
Schwartz, L.M.2
-
15
-
-
79958180106
-
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
-
Panichi V., Rosati A., Bigazzi R., et al. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrol Dial Transplant 2011, 26:2641-2648. RISCAVID Study Group.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2641-2648
-
-
Panichi, V.1
Rosati, A.2
Bigazzi, R.3
-
16
-
-
83655163838
-
Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan
-
Fukuma S., Yamaguchi T., Hashimoto S., et al. Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. Am J Kidney Dis 2012, 59:108-116.
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 108-116
-
-
Fukuma, S.1
Yamaguchi, T.2
Hashimoto, S.3
-
17
-
-
84871247763
-
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis
-
Koulouridis I., Alfayez M., Trikalinos T.A., Balk E.M., Jaber B.L. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis 2013, 61:44-56.
-
(2013)
Am J Kidney Dis
, vol.61
, pp. 44-56
-
-
Koulouridis, I.1
Alfayez, M.2
Trikalinos, T.A.3
Balk, E.M.4
Jaber, B.L.5
-
18
-
-
0030008101
-
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients
-
Braun J., Oldendorf M., Moshage W., Heidler R., Zeitler E., Luft F.C. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996, 27:394-401.
-
(1996)
Am J Kidney Dis
, vol.27
, pp. 394-401
-
-
Braun, J.1
Oldendorf, M.2
Moshage, W.3
Heidler, R.4
Zeitler, E.5
Luft, F.C.6
-
19
-
-
3543139492
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
-
Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2208-2218
-
-
Block, G.A.1
Klassen, P.S.2
Lazarus, J.M.3
Ofsthun, N.4
Lowrie, E.G.5
Chertow, G.M.6
-
20
-
-
79955624020
-
Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients
-
Noordzij M., Cranenburg E.M., Engelsman L.F., et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 2011, 26:1662-1669. NECOSAD Study Group.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1662-1669
-
-
Noordzij, M.1
Cranenburg, E.M.2
Engelsman, L.F.3
-
21
-
-
80052561697
-
Arterial calcification in chronic kidney disease: key roles for calcium and phosphate
-
Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011, 109:697-711.
-
(2011)
Circ Res
, vol.109
, pp. 697-711
-
-
Shanahan, C.M.1
Crouthamel, M.H.2
Kapustin, A.3
Giachelli, C.M.4
-
22
-
-
0042885985
-
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
-
London G.M., Guerin A.P., Marchais S.J., Métivier F., Pannier B., Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1731-1740
-
-
London, G.M.1
Guerin, A.P.2
Marchais, S.J.3
Métivier, F.4
Pannier, B.5
Adda, H.6
-
23
-
-
77954594687
-
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
-
Strippoli G.F. Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol. Trials 2010, 11:70. Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE).
-
(2010)
Trials
, vol.11
, pp. 70
-
-
Strippoli, G.F.1
|